We are proud to announce the release of our 2024 Environmental, Social and Governance (ESG) Report. The report includes information related to our non-financial performance last year and underscores how our mission to deliver life-enhancing renal care is intrinsically linked to our commitment to ESG excellence.
2024 marked a pivotal chapter as we integrated further with M42, our strategic investor, joining its newly created Global Patient Care platform earlier this year. This development is allowing us to strengthen our ability to deliver high-quality, digitally connected care across borders - combining Diaverum’s clinical expertise with M42’s innovation in AI, data, and precision health.
ESG is woven into Diaverum’s corporate strategy and operations, ensuring a stakeholder-focused approach to how we conduct business. To support this, we have developed our own ESG framework, structured around five strategic pillars that reflect our commitment to continuously improving non-financial performance. Each of such pillars is explored in detail throughout the 2024 report, along with our ambitions for 2025 and the policies already in place to support them.
2024 ESG pillar performance highlights:
- Patients: we continued to strengthen our patient-centric approach by expanding our proprietary Patient Experience Framework to over 316 clinics, covering 95% of operating countries. Through tools like the d.CARE smartphone app and expanded educational resources, we enhanced health literacy and patient empowerment.
- Access to care: beyond dialysis, Diaverum deepened its commitment to preventive healthcare, with pre-dialysis programmes in 11 countries and structured diabetes management initiatives in Romania and Brazil. We supported community-based CKD awareness efforts and promoted kidney health. Meanwhile, our holiday dialysis programme, d.HOLIDAY, delivered over 76,000 treatments in 2024 and launched d.HOLIDAY Fly Back - an initiative that ensures patients on transplant waiting lists can travel and return safely for surgery when needed, at no personal cost.
- Employees and well-being: Diaverum’s people-first culture was reflected in strong engagement scores. 82% of employees recommended Diaverum as a good place to work and 88% felt motivated to improve services to patients, well above our 2025 ambitions of 70% and 75% respectively.
- Operating responsibly: we reinforced our governance standards through enhanced compliance training, expanded ESG oversight, and stronger integration into risk management, with a 100% training completion rate achieved in 2024. At the same time, cybersecurity and data protection remained central to securing patient information and digital platforms.
- Environment: in line with our net zero 2050 ambition, we enhanced our carbon footprint accounting across Scopes 1 and 2, improved our Scope 3 accounting, and launched a climate transition roadmap. Our solar energy programme, implemented in 23 clinics, produced 795 MWh of renewable energy, while efforts to reduce water usage and clinical waste continued across all 24 countries of operation. Additionally, we launched a global climate risk assessment and a performance dashboard to monitor environmental impact.
Rafael Romanini, Diaverum Group Chief Executive Officer, stated: “As global demand for dialysis grows, we remain focused on providing life-enhancing renal care - wherever and whenever it is needed. ESG is increasingly shaping our strategy, decisions, and culture, ensuring we serve not only our patients, but also the communities and planet we all depend on.
“Our ESG journey is grounded in the belief that responsible, sustainable healthcare is not only possible - but essential. Together with M42, we are broadening access to kidney care, improving outcomes, and helping build more resilient, sustainable healthcare systems”.
Stephanie de Sury, Global ESG Manager, added: “Throughout 2024, we focused on embedding sustainability more deeply into our core strategy and daily operations. This report is a testament to the collective efforts of our teams across 24 countries. It also reflects our ongoing commitment to transparency and best practice reporting.
“While we are proud of our progress, we remain committed to growing responsibly and further minimising our environmental impact”.
Looking ahead: healthcare with purpose
As healthcare systems worldwide seek more sustainable and equitable ways to deliver care, Diaverum is poised to lead - with Competence, Passion, and Inspiration. Our ambition is clear: to evolve from a treatment provider to an enabler of fulfilling lives. That means supporting patients beyond dialysis, strengthening health systems, and embedding sustainability into every decision we make.
While the implementation of the Corporate Sustainability Reporting Directive (CSRD) has been deferred by the EU’s Omnibus Directive, we will launch a new materiality assessment in 2025 and continue aligning our strategy with global best practices.
We invite you to read more in our 2024 ESG Report, available below.